University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Michael Conte, M.D.

Co-director of the Heart and Vascular Center

Dr. Michael Conte, a vascular surgeon, is co-director of the UCSF Heart and Vascular Center and chief of Vascular and Endovascular Surgery. He specializes in diseases of the aorta and its major branches, aneurysms, carotid artery disease and peripheral artery disease (PAD). He also treats diabetic vascular disease and performs complex revascularization to preserve limb function and prevent amputation. Conte led the largest multi-center clinical trial to date, examining leg bypass surgery in patients with severe PAD and is studying angioplasty and bypass surgery failure and approaches to identify patients at risk.

Conte earned a medical degree at Albert Einstein College of Medicine in New York City. He completed a surgical residency at New York Hospital-Cornell Medical Center and vascular surgery training as a John Homan's Fellow at Brigham and Women's Hospital in Boston and Harvard Medical School. He is a member of the Society for Vascular Surgery and Society of University Surgeons. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He serves on the editorial boards for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery and Vascular.


Center for Limb Preservation
400 Parnassus Ave., Room A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. — 5 p.m.

Vascular and Endovascular Surgery
400 Parnassus Ave., Suite A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. – 5 p.m.

Vascular Laboratories at Parnassus
505 Parnassus Ave., Eighth Floor, Room M-830A
San Francisco, CA 94143
Phone: (415) 353-1286
Fax: (415) 353-8706

Hours: Monday to Friday
9 a.m. – 5:30 p.m.

Conditions & Treatments

More about Michael Conte

Additional Languages



Albert Einstein College of Medicine 1986


Cornell Medical Center, General Surgery 1993


Brigham and Women's Hospital, Vascular Surgery 1991
Harvard Medical School, Vascular Surgery 1994
Brigham and Women's Hospital, Vascular Surgery 1994

Selected Research and Publications

  1. Grenon SM, Owens CD, Nosova EV, Hughes-Fulford M, Alley HF, Chong K, Perez S, Yen PK, Boscardin J, Hellmann J, Spite M, Conte MS. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). J Am Heart Assoc. 2015; 4(8).
  2. Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease. Vasc Endovascular Surg. 2015 Jul 5.
  3. Conte MS, Farber A. Revascularization for chronic limb-threatening ischaemia. Br J Surg. 2015 Aug; 102(9):1007-9.
  4. Oresanya L, Zhao S, Gan S, Fries BE, Goodney PP, Covinsky KE, Conte MS, Finlayson E. Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study. JAMA Intern Med. 2015 Jun 1; 175(6):951-7.
  5. Parikh SA, Leis JF, Chaffee KG, Call TG, Hanson CA, Ding W, Chanan-Khan AA, Bowen D, Conte M, Schwager S, Slager SL, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes. Cancer. 2015 Sep 1; 121(17):2883-91.
  6. Vartanian SM, Conte MS. Surgical intervention for peripheral arterial disease. Circ Res. 2015 Apr 24; 116(9):1614-28.
  7. Kibbe MR, Dardik A, Velazquez OC, Conte MS. The vascular surgeon-scientist: A 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program. J Vasc Surg. 2015 Apr; 61(4):1050-1057.e3.
  8. Akagi D, Chen M, Toy R, Chatterjee A, Conte MS. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J. 2015 Mar 16.
  9. Yiu WK, Conte MS. Primary stenting in femoropopliteal occlusive disease - what is the appropriate role? Circ J. 2015 Mar 25; 79(4):704-11.
  10. Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015 Mar 10; 65(9):931-41.
  11. Tsang M, Shanafelt TD, Call TG, Ding W, Chanan-Khan A, Leis JF, Nowakowski GS, Bowen D, Conte M, Schwager SM, Slager SL, Kay NE, Hanson CA, Parikh SA. The efficacy of ibrutinib in the treatment of Richter syndrome. Blood. 2015 Mar 5; 125(10):1676-8.
  12. Conte MS, Pomposelli FB. Introduction. J Vasc Surg. 2015 Mar; 61(3 Suppl):1S.
  13. Malgor RD, Alalahdab F, Elraiyah TA, Rizvi AZ, Lane MA, Prokop LJ, Phung OJ, Farah W, Montori VM, Conte MS, Murad MH. A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg. 2015 Mar; 61(3 Suppl):54S-73S.
  14. Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS, Murad MH. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015 Mar; 61(3 Suppl):42S-53S.
  15. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg. 2015 Mar; 61(3 Suppl):2S-41S.
  16. Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg. 2015 Apr; 29(3):534-42.
  17. Nosova EV, Conte MS, Grenon SM. Advancing beyond the "heart-healthy diet" for peripheral arterial disease. J Vasc Surg. 2015 Jan; 61(1):265-74.
  18. Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS. The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells. PLoS One. 2014; 9(11):e113480.
  19. Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM. Relationship between kidney disease and endothelial function in peripheral artery disease. J Vasc Surg. 2014 Dec; 60(6):1605-11.
  20. Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM. Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the Database. Circulation. 2014 Nov 11; 130(20):1812-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.